Bard Associates Inc. Boosts Stock Position in Utah Medical Products, Inc. (NASDAQ:UTMD)

Bard Associates Inc. boosted its holdings in shares of Utah Medical Products, Inc. (NASDAQ:UTMD) by 5.0% in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 21,032 shares of the medical instruments supplier’s stock after buying an additional 1,002 shares during the quarter. Bard Associates Inc. owned 0.64% of Utah Medical Products worth $1,185,000 at the end of the most recent reporting period.

Other institutional investors have also recently made changes to their positions in the company. American Century Companies Inc. raised its position in shares of Utah Medical Products by 8.6% in the fourth quarter. American Century Companies Inc. now owns 8,135 shares of the medical instruments supplier’s stock worth $500,000 after acquiring an additional 643 shares during the period. LPL Financial LLC acquired a new stake in Utah Medical Products in the 4th quarter worth about $208,000. JPMorgan Chase & Co. increased its position in shares of Utah Medical Products by 14.8% during the fourth quarter. JPMorgan Chase & Co. now owns 79,703 shares of the medical instruments supplier’s stock worth $4,899,000 after purchasing an additional 10,292 shares in the last quarter. Geode Capital Management LLC raised its position in shares of Utah Medical Products by 0.9% in the fourth quarter. Geode Capital Management LLC now owns 97,937 shares of the medical instruments supplier’s stock valued at $6,022,000 after buying an additional 857 shares during the last quarter. Finally, Wells Fargo & Company MN lifted its stake in shares of Utah Medical Products by 24.9% in the fourth quarter. Wells Fargo & Company MN now owns 1,927 shares of the medical instruments supplier’s stock worth $118,000 after buying an additional 384 shares in the last quarter. Hedge funds and other institutional investors own 69.60% of the company’s stock.

Utah Medical Products Trading Down 1.0%

UTMD opened at $55.70 on Friday. The firm’s 50-day moving average price is $56.32 and its 200 day moving average price is $56.63. Utah Medical Products, Inc. has a twelve month low of $51.26 and a twelve month high of $69.30. The firm has a market capitalization of $181.03 million, a PE ratio of 14.89 and a beta of 0.31.

Utah Medical Products (NASDAQ:UTMD) last issued its earnings results on Thursday, July 24th. The medical instruments supplier reported $0.94 earnings per share (EPS) for the quarter. Utah Medical Products had a return on equity of 10.50% and a net margin of 32.34%. The business had revenue of $9.95 million during the quarter.

Utah Medical Products Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, October 2nd. Stockholders of record on Wednesday, September 17th will be paid a $0.305 dividend. This represents a $1.22 dividend on an annualized basis and a dividend yield of 2.2%. The ex-dividend date of this dividend is Wednesday, September 17th. Utah Medical Products’s payout ratio is 32.62%.

About Utah Medical Products

Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.